SPERLING SCOTT M 4

What Happened

• Scott M. Sperling, a director of Thermo Fisher Scientific (TMO), was credited with 89.78 deferred stock units (derivative award) on March 28, 2026. The units are valued at $473.36 each, for an aggregate value of approximately $42,972. This was an award (code A), not an open-market purchase or sale.

Key Details

• Transaction date: March 28, 2026; Form 4 filed March 31, 2026 (filing appears timely).
• Units credited: 89.78 deferred stock units at $473.36 per unit (total ≈ $42,972).
• Security type: Derivative — units convertible into common stock on a 1-for-1 basis (Footnote F1).
• Plan details: Units were credited under the Issuer’s Deferred Compensation Plan for Directors; directors’ retainers are deferred quarterly as common stock units and are distributable as stock upon cessation of director service or a change of control (Footnote F2).
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• This is a routine director compensation credit (deferred stock units), not a market purchase or sale; such awards reflect compensation rather than an independent buy/sell signal. The units convert 1-for-1 to common shares when distributed (e.g., when director service ends or on a change of control).